AMG vs GGAL

AMG exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust fundamentals across profitability, leverage, and operating efficiency. Despite the absence of an Altman Z-Score, the company shows low distress risk with a healthy Debt/Equity ratio of 0.56 and exceptional liquidity (Current Ratio: 126.47). The stock trades above the Graham Number ($207.58) but below the growth-based intrinsic value ($478.2), supported by strong earnings growth (YoY EPS +81.8%) and analyst target consensus of $364.14. However, weak insider sentiment and minimal dividend yield temper near-term catalysts.

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 2/9 and a massive valuation gap where the current price ($47.93) trades at a significant premium to the Graham Number ($8.34) and Intrinsic Value ($6.23). While long-term price performance has been exceptional, current fundamentals show severe deterioration, including a negative YoY revenue growth of 10% and a catastrophic earnings surprise trend (-149.13% over the last 4 quarters). The dividend is unsustainable with a payout ratio of 123.58%, suggesting capital erosion. Despite bullish analyst targets, the hard data indicates a high-risk, overvalued asset.